Baxter International Surges 1.24% on $230M Trading Volume, Ranks 446th in Market Activity

Baxter International (BAX) surged 1.24% on Sept. 26, with a trading volume of $0.23 billion, marking a 43.69% increase from the previous day and ranking 446th in market activity. The stock's performance aligns with recent operational updates and market positioning shifts observed in its sector.

Recent developments highlight Baxter's strategic focus on expanding its dialysis product portfolio, with a new home therapy initiative announced to cater to growing patient demand. Analysts noted that this expansion could strengthen the company's market share in chronic disease management, a sector projected to see sustained growth through 2026.

Internal restructuring efforts also contributed to investor sentiment. The company confirmed plans to consolidate manufacturing operations in Europe, aiming to reduce costs by 8% annually over the next three years. While labor negotiations remain ongoing, the restructuring is expected to enhance operational efficiency without significant short-term disruptions.

To run this back-test accurately I need a few quick clarifications: 1. Stock universe • Should I use all common stocks listed on the NYSE + Nasdaq + AMEX, or a different universe (e.g., S&P 1500, Russell 3000, your own list)? 2. Selection timing • The “top-500 by daily trading volume” can only be known after the market closes. - Typical implementation: rank stocks by yesterday’s volume, buy them at today’s open, sell at today’s close (1-day holding period). Is this the rule you want? 3. Weighting method • Equal-weight across the 500 names each day, or volume-weighted / value-weighted? 4. Trading frictions • Assume zero transaction costs and perfect liquidity, or should I include an estimated commission/slippage? Please let me know (a quick “yes” or your preferred choices). Once I have this I’ll pull the data and run the back-test.